PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for June 19, 2002 Subscribe to this News Feed    
 

Eliminate Varicose Veins in Just 45 Minutes! biolitecs ELVeS Laser Treatment

biolitec, Inc. announced today that its new ELVeS laser procedure for the treatment of superficial reflux of the greater saphenous vein has received clearance from the Food and Drug Administration (FDA). (ELVeS: Endo Laser Vein System; pronounced, Elvis".)

NEWS RELEASE


For more information please contact:
Jim White
Director of Marketing
(800) 934-2377, Ext. 254
jim.white@biolitec.com


Eliminate Varicose Veins in Just 45 Minutes!
biolitecs ELVeS(TM) Laser Treatment


EAST LONGMEADOW, MA; June 13, 2002 -- biolitec, Inc. announced today that its new ELVeS laser procedure for the treatment of superficial reflux of the greater saphenous vein has received clearance from the Food and Drug Administration (FDA). (ELVeS: Endo Laser Vein System; pronounced, Elvis".)

More than half of Americans over the age of 65 suffer from venous disease, the most common form being varicose veins. For the more than 80 million people in the United States afflicted with varicose veins, this revolutionary new laser procedure means freedom from serious leg pain and an affordable solution to an unsightly problem," said Kelly B. Moran, biolitecs Chief Operating Officer.

biolitecs new minimally invasive laser procedure offers an effective alternative to the treatments predecessor, the surgical stripping of veins -- surgery that requires general anesthesia, hospitalization, and a prolonged recovery time. In contrast, the new biolitec ELVeS laser treatment is an outpatient procedure that takes only 45 minutes, leaves no scars, and requires only minimal recovery time.

The biolitec ELVeS procedure takes under an hour to complete, is less expensive than surgical alternatives and can be performed in a physicians office -- and when finished, patients walk away, returning to daily life as usual," said Moran. ELVeS is a life-changing procedure. For many it will restore their ability to walk and perform routine physical activities without pain or discomfort. Others will regain pride in their legs appearance and feel free to wear shorts or go to the beach again."

In addition, Lowell Kabnick, MD, vascular surgeon and Director of the Vein Institute of New Jersey said, early results with ELVeS produced a 98-plus percent efficacy rate with all patients reporting a high rate of satisfaction."

The ELVeS laser treatment is rather simple: the practitioner first locates the greater saphenous vein with ultrasound and then administers local anesthesia to the treatment site. Next, a thin, flexible fiber from biolitecs diode laser is introduced into the saphenous vein and laser light then seals the vein -- eliminating the cause of the varicosity.

Established in 1987, biolitec, Inc. manufactures advanced lasers and fiber optic delivery systems for medical and dental applications. Its strength as a vertically integrated manufacturer enables the production of top quality lasers, fibers, handpieces, and accessories -- as well as ongoing research into new medical breakthroughs such as photodynamic therapy (PDT).

For more information, please call biolitec at (800) 934-2377 or visit their website at www.biolitec-us/specialties.com.

biolitec, Inc.
515 Shaker Rd.
East Longmeadow, MA 01028

###

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Jim White
biolitec, Inc.
(800) 934-2377
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.